302 related articles for article (PubMed ID: 21152689)
21. Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline.
Giovacchini G; Breeuwsma AJ
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):354-66. PubMed ID: 23013665
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J
Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
[TBL] [Abstract][Full Text] [Related]
23. PET with radiolabeled aminoacid.
Crippa F; Alessi A; Serafini GL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
[TBL] [Abstract][Full Text] [Related]
24. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
[TBL] [Abstract][Full Text] [Related]
25. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
Powles T; Murray I; Brock C; Oliver T; Avril N
Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
[TBL] [Abstract][Full Text] [Related]
27. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?
Cobben DC; Elsinga PH; Hoekstra HJ; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Groen HM
J Nucl Med; 2004 Oct; 45(10):1677-82. PubMed ID: 15471832
[TBL] [Abstract][Full Text] [Related]
28. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
30. Advances in evaluation of primary brain tumors.
Chen W; Silverman DH
Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
[TBL] [Abstract][Full Text] [Related]
31. Applications of PET imaging with radiolabelled choline (11C/18F-choline).
Kirienko M; Sollini M; Lopci E; Versari A; Chiti A
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):83-94. PubMed ID: 25677590
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
Buck AK; Herrmann K; Shen C; Dechow T; Schwaiger M; Wester HJ
Methods; 2009 Jun; 48(2):205-15. PubMed ID: 19318128
[TBL] [Abstract][Full Text] [Related]
33. Non-[18F]FDG PET in clinical oncology.
Groves AM; Win T; Haim SB; Ell PJ
Lancet Oncol; 2007 Sep; 8(9):822-30. PubMed ID: 17765191
[TBL] [Abstract][Full Text] [Related]
34. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
[TBL] [Abstract][Full Text] [Related]
35. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
[TBL] [Abstract][Full Text] [Related]
36. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
[TBL] [Abstract][Full Text] [Related]
37. PET-CT for treatment planning in prostate cancer.
Picchio M; Crivellaro C; Giovacchini G; Gianolli L; Messa C
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):245-68. PubMed ID: 19293771
[TBL] [Abstract][Full Text] [Related]
38. [Positron-emission tomography in urooncology].
Maurer T; Kübler H; Gschwend JE; Eiber M
Urologe A; 2015 Jul; 54(7):983-91. PubMed ID: 26109122
[TBL] [Abstract][Full Text] [Related]
39. Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Herrmann K; Ott K; Buck AK; Lordick F; Wilhelm D; Souvatzoglou M; Becker K; Schuster T; Wester HJ; Siewert JR; Schwaiger M; Krause BJ
J Nucl Med; 2007 Dec; 48(12):1945-50. PubMed ID: 18006614
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
